Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- E.coli
Protein structure
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| EGFR WT | EGFRWT-HB001 | Human | E.coli | Biotinylated Human HLA-A*11:01&B2M&EGFR WT (KITDFGLAK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EGFR WT (25–305) AviHis |
| CT83 | CT83-HP001 | Human | HEK293 | Human HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CT83 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB008 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&Influenza M1₅₈₋₆₆ (GILGFVFTL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| KRAS G12C | KRASG12C-HB002 | Human | E.coli | Biotinylated Human HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12C (25–305) AviHis |
| KRAS G12V | KRASG12V-HP001 | Human | E.coli | Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| KRAS G12D | KRASG12D-HP009 | Human | HEK293 | Human HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| Qa-1b | QA1B-HB001 | Mouse | HEK293 | Biotinylated Mouse Qa-1b&B2M&Qdm (AMAPRTLLL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Qa-1b (23–296) AviHis |
| GP100 | GP100-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | GP100 (25–305) AviHis |
| KRAS G12V | KRASG12V-HP006 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB009 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&Foxp3 (TLIRWAILEA) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| P53 R175H | P53R175H-HB001 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | P53 R175H (25–305) AviHis |
| LILRB2 | LILRB2-CP002 | Cynomolgus | HEK293 | Cynomolgus LILRB2/CD85d/ILT4 Protein Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB2 (24–457) Fc |
| GP100 | GP100-HB003 | Human | E.coli | Biotinylated Human HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | GP100 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HP002 | Human | E.coli | Human HLA-A*02:01&B2M&HKDC1 (KVDRFLYHM) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| MAGE-A3 | MAGEA3-HB001 | Human | E.coli | Biotinylated Human HLA-A*01:01&B2M&MAGE-A3 (EVDPIGHLY) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A3 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HB001 | Human | HEK293 | Biotinylated Human NY-ESO-1 TCR&CD3 Complex VLP Purity > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 |
| HLA-A*02:01 | HLAA0201-HP003 | Human | E.coli | Human HLA-A*02:01&B2M&GSTO-2 (LLWPWFERL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| KRAS G12C | KRASG12C-HP004 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12C (25–305) AviHis |
| HLA-B*27:05 | HLAB2705-HP001 | Human | HEK293 | HLA-B*27:05 (25–305) AviHis | |
| LILRB2 | LILRB2-HB001 | Human | HEK293 | Non-biotinylated Human LILRB2/CD85d/ILT4 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB2 (22–457) AviHis |